Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Association of mutation and expression of the brother of the regulator of imprinted sites (BORIS) gene with breast cancer progression.

Oncotarget - 26 May 2023

Akhtar Mohammad Salman, Akhter Naseem, Talat Arshi, Alharbi Raed A, Sindi Abdulmajeed A A, Klufah Faisal, Alyahyawi Hanan E, Alruwetei Abdulmohsen, Ahmad Abrar, Zamzami Mazin A, Deo Svs, Husain Syed Akhtar, Badi Osama A, Khan Mohammad Jahir

Abstract excerpt

INTRODUCTION: The BORIS, 11 zinc-finger transcription factors, is a member of the cancer-testis antigen (CTA) family. It is mapped to chromosome number 20q13.2 and this region is genetically linked to the early onset of breast cancer. The current study analyzed the correlation between BORIS mutations and the expression of the protein in breast cancer cases. MATERIALS AND METHODS: A population-based study...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Breast
Share to Breast Neoplasms

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Cell Line, Tumor

Share to Gene Expression Regulation, Neoplastic

Share to Mutation

Share to Transcription Factors

Source

Open in PubMed Open full text

Identifiers

PMID: 37235839
DOI: 10.18632/oncotarget.28442
PMCID: PMC10219660

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 11 closest

Association of mutation and expression of the brother of the regulator of imprinted sites (BORIS) gene with breast cancer progression.PMID 37235839Read ↗

BORIS, a paralogue of the transcription factor, CTCF, is aberrantly expressed in breast tumoursSemantic proximity Read ↗

The Potential of BORIS Detected in the Leukocytes of Breast Cancer Patients as an Early Marker of TumorigenesisSemantic proximity Read ↗

CTCFL/BORIS Is a Methylation-Independent DNA-Binding Protein That Preferentially Binds to the Paternal <i>H19</i> Differentially Methylated RegionSemantic proximity Read ↗

BORIS Binding to the Promoters of Cancer Testis Antigens, MAGEA2, MAGEA3, and MAGEA4, Is Associated with Their Transcriptional Activation in Lung CancerSemantic proximity Read ↗

Expression of the CTCF-paralogous cancer-testis gene, brother of the regulator of imprinted sites (BORIS), is regulated by three alternative promoters modulated by CpG methylation and by CTCF and p53 transcription factorsSemantic proximity Read ↗

Role of MiRNAs and It’s Single Nucleotide Polymorphism in Breast CancerSemantic proximity Read ↗

In silico SNP analysis of the breast cancer antigen NY-BR-1.Semantic proximity Read ↗

Expression of <i>BORIS</i> in melanoma: Lack of association with <i>MAGE‐A1</i> activationSemantic proximity Read ↗

Conditional Expression of the CTCF-Paralogous Transcriptional Factor BORIS in Normal Cells Results in Demethylation and Derepression of MAGE-A1 and Reactivation of Other Cancer-Testis GenesSemantic proximity Read ↗

Immunohistochemical expression and mutation study of Prohibitin gene in Indian female breast cancer cases.Semantic proximity Read ↗

The association between rs1972820 and the risk of breast cancer in Isfahan population.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.